An appraisal of smoking cessation aids.
OBJECTIVE
Smoking cessation is the single most efficacious intervention to reduce and prevent smoking-associated morbidity and mortality. This review presents an updated summary of current treatment options. Resources available for management of smoking cessation efforts and variables that may guide treatment of subgroups of patients have also been highlighted.


RESULTS
The US Department of Health and Human Services released updated guidelines for treatment of smoking cessation in 2008. Recent meta-analyses have reviewed the newly Food and Drug Administration approved drug, varenicline, as well as some new nonpharmacological approaches to treating tobacco dependence.


CONCLUSIONS
Several pharmacologic and nonpharmacologic aids have proven efficacy in smoking cessation management. The best results are obtained by combining modalities. Tailoring therapy improves success rate.
Mundey
Kavita
K
Division of Pulmonary, Critical Care and Sleep Medicine, Medical College of Wisconsin, 9200 W. Wisconsin Aveue, Milwaukee, WI 53226, USA. kmundey@mcw.edu
D003362:Cost-Benefit Analysis; D003376:Counseling; D006801:Humans; D018722:Nicotinic Agonists / Q000627:therapeutic use; D015995:Prevalence; D016540:Smoking Cessation / Q000191:economics / Q000379:methods*; D014029:Tobacco Use Disorder / Q000191:economics / Q000453:epidemiology / Q000628:therapy*; D014481:United States / Q000453:epidemiology; D014612:Vaccines / Q000627:therapeutic use
D018722:Nicotinic Agonists; D014612:Vaccines